Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia

The standard-of-care treatment for biliary atresia (BA) is surgical restoration of bile flow by Kasai portoenterostomy. We aimed to study serum interleukin- (IL-) 12p40, a natural antagonist for the proinflammatory IL-12p70, and its relation to surgical outcomes of BA. The study included 75 infants...

Descripción completa

Detalles Bibliográficos
Autores principales: Goda, Shaimaa Samy, Khedr, Mohamed Ahmed, Elshenawy, Soha Zaki, Ibrahim, Tarek Mohamed, El-Araby, Hanaa Ahmed, Sira, Mostafa Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447261/
https://www.ncbi.nlm.nih.gov/pubmed/28588613
http://dx.doi.org/10.1155/2017/9089068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447261/
https://www.ncbi.nlm.nih.gov/pubmed/28588613
http://dx.doi.org/10.1155/2017/9089068

Ejemplares similares